Most revenue
- UNH UnitedHealth Group$447.57B
- MCK McKesson$403.43B
- CVS CVS Health$402.07B
- COR Cencora$321.33B
- CI Cigna$274.90B
Most profit
- JNJ Johnson & Johnson$26.80B
- LLY Eli Lilly$20.64B
- MRK Merck$18.25B
- UNH UnitedHealth Group$12.06B
- GILD Gilead Sciences$8.51B
Highest dividend yield
Rank every health care company →Longest record of raises
- ZTS ZoetisRaised 9+ yrs
- LMAT LeMaitre VascularRaised 9+ yrs
- LLY Eli LillyRaised 9+ yrs
- MCK McKessonRaised 9+ yrs
- UNH UnitedHealth GroupRaised 9+ yrs
Every health care company, by market value
| # | Company | Market value | Price | 1 day | 1 yr | 30 days | Industry |
|---|---|---|---|---|---|---|---|
| 1 | LLY Eli Lilly and Company | $1.33T | $1,410.99 | −0.5% | +64.6% | Pharmaceutical preparations | |
| 2 | JNJ Johnson & Johnson | $651.32B | $270.56 | −1.0% | +46.5% | Pharmaceutical preparations | |
| 3 | ABBV AbbVie Inc | $510.41B | $288.84 | −2.0% | +36.4% | Pharmaceutical preparations | |
| 4 | MRK Merck & Company Inc | $366.03B | $148.36 | −0.8% | +77.6% | Pharmaceutical preparations | |
| 5 | UNH UnitedHealth Group Incorporated | $359.43B | $400.44 | −1.6% | +20.4% | Hospital and medical service plans | |
| 6 | TMO Thermo Fisher Scientific Inc | $252.93B | $682.65 | −2.1% | +20.7% | Measuring and controlling devices | |
| 7 | AMGN Amgen Inc | $251.64B | $465.45 | −0.1% | +60.3% | Biological products | |
| 8 | GILD Gilead Sciences Inc | $211.27B | $170.33 | −0.2% | +45.7% | Biological products | |
| 9 | ABT Abbott Laboratories | $190.62B | $110.16 | +3.7% | −8.7% | Pharmaceutical preparations | |
| 10 | PFE Pfizer Inc | $174.81B | $30.67 | +0.5% | +33.2% | Pharmaceutical preparations | |
| 11 | DHR Danaher Corporation | $160.38B | $227.97 | −1.8% | +6.6% | Industrial instruments for measurement, display, and control | |
| 12 | ISRG Intuitive Surgical Inc | $151.44B | $436.87 | +1.1% | −18.2% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 13 | VRTX Vertex Pharmaceuticals, Inc. | $140.20B | $553.15 | −1.0% | +30.0% | Pharmaceutical preparations | |
| 14 | BMY Bristol-Myers Squibb Company | $128.82B | $63.02 | +0.9% | +42.8% | Pharmaceutical preparations | |
| 15 | MDT Medtronic PLC | $127.01B | $99.29 | +2.9% | +13.1% | Electromedical and electrotherapeutic apparatus | |
| 16 | SYK Stryker Corporation | $116.80B | $306.81 | +5.1% | −12.9% | Surgical and medical instruments and apparatus | |
| 17 | MCK McKesson Corporation | $116.40B | $998.38 | +0.4% | +23.5% | Drugs, proprietaries and druggists' sundries | |
| 18 | CVS CVS Health Corp | $113.20B | $88.51 | −1.9% | +16.7% | Drug stores and proprietary stores | |
| 19 | REGN Regeneron Pharmaceuticals Inc | $99.44B | $961.26 | +3.6% | +48.2% | Pharmaceutical preparations | |
| 20 | HCA HCA Holdings Inc | $97.71B | $467.73 | −1.1% | +2.4% | General medical and surgical hospitals | |
| 21 | ELV Elevance Health Inc | $89.36B | $413.60 | −1.5% | +33.0% | Hospital and medical service plans | |
| 22 | MRNA Moderna Inc | $88.16B | $220.83 | −0.4% | +713.1% | Biological products | |
| 23 | CI Cigna Corp | $78.00B | $295.19 | −1.0% | +23.5% | Hospital and medical service plans | |
| 24 | COR Cencora Inc. | $64.47B | $337.84 | +2.1% | +0.8% | Drugs, proprietaries and druggists' sundries | |
| 25 | BSX Boston Scientific Corp | $64.24B | $44.32 | +5.6% | −56.0% | Surgical and medical instruments and apparatus | |
| 26 | CAH Cardinal Health Inc | $59.15B | $254.33 | +1.5% | +34.6% | Drugs, proprietaries and druggists' sundries | |
| 27 | BDX Becton Dickinson and Company | $54.10B | $198.60 | +0.4% | +44.9% | Surgical and medical instruments and apparatus | |
| 28 | EW Edwards Lifesciences Corp | $53.76B | $93.26 | +1.4% | +13.1% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 29 | IDXX IDEXX Laboratories, Inc. | $52.92B | $671.64 | +21.9% | +6.7% | In vitro and in vivo diagnostic substances | |
| 30 | A Agilent Technologies Inc | $49.30B | $174.87 | −3.5% | +22.9% | Laboratory analytical instruments | |
| 31 | HUM Humana Inc | $49.28B | $410.41 | −1.0% | +49.5% | Hospital and medical service plans | |
| 32 | WAT Waters Corporation | $44.17B | $449.53 | −2.9% | +28.6% | Laboratory analytical instruments | |
| 33 | ILMN Illumina Inc | $43.67B | $288.79 | +3.3% | +195.3% | Laboratory analytical instruments | |
| 34 | IQV IQVIA Holdings Inc | $42.59B | $258.44 | −3.3% | +19.4% | Commercial physical and biological research | |
| 35 | ONC BeiGene, Ltd. ‡ | $41.62B | $366.06 | — | +16.0% | Pharmaceutical preparations | |
| 36 | BIIB Biogen Inc | $36.81B | $249.01 | −1.8% | +61.4% | Biological products | |
| 37 | GEHC GE HealthCare Technologies Inc. | $35.97B | $79.55 | +3.9% | +6.4% | X-ray apparatus and tubes and related irradiation apparatus | |
| 38 | ZTS Zoetis Inc | $34.37B | $83.18 | +4.3% | −41.0% | Pharmaceutical preparations | |
| 39 | MTD Mettler-Toledo International Inc | $33.63B | $1,678.19 | +0.2% | +18.5% | Laboratory analytical instruments | |
| 40 | CNC Centene Corp | $32.94B | $66.53 | −2.8% | +88.1% | Hospital and medical service plans | |
| 41 | RMD ResMed Inc | $32.76B | $232.94 | +1.3% | −4.6% | Surgical and medical instruments and apparatus | |
| 42 | DXCM DexCom Inc | $31.61B | $84.76 | +3.0% | +45.6% | Surgical and medical instruments and apparatus | |
| 43 | ALNY Alnylam Pharmaceuticals Inc ‡ | $30.38B | $226.79 | — | −52.6% | Pharmaceutical preparations | |
| 44 | LH Laboratory Corporation of America Holdings | $28.87B | $355.59 | −1.6% | +41.4% | Medical laboratories | |
| 45 | WST West Pharmaceutical Services Inc | $28.41B | $407.88 | −1.1% | +45.1% | Surgical and medical instruments and apparatus | |
| 46 | DGX Quest Diagnostics Incorporated | $27.59B | $250.81 | −0.4% | +44.9% | Medical laboratories | |
| 47 | ROIV Roivant Sciences Ltd | $26.81B | $37.11 | +1.6% | +101.6% | Pharmaceutical preparations | |
| 48 | UTHR United Therapeutics Corporation | $25.15B | $586.48 | −0.8% | +41.2% | Pharmaceutical preparations | |
| 49 | INCY Incyte Corporation | $24.47B | $120.04 | −0.3% | +28.4% | Commercial physical and biological research | |
| 50 | STE STERIS plc | $22.75B | $233.35 | +2.7% | +0.1% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 51 | VTRS Viatris Inc | $21.44B | $18.67 | −1.9% | +86.5% | Pharmaceutical preparations | |
| 52 | THC Tenet Healthcare Corporation | $21.37B | $268.50 | +2.5% | +31.2% | General medical and surgical hospitals | |
| 53 | MEDP Medpace Holdings Inc | $19.38B | $692.68 | +2.8% | +19.3% | Commercial physical and biological research | |
| 54 | ZBH Zimmer Biomet Holdings Inc | $18.57B | $97.35 | +3.0% | −2.2% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 55 | RVTY Revvity Inc. | $16.92B | $151.60 | −3.4% | +62.4% | Laboratory analytical instruments | |
| 56 | EXEL Exelixis Inc | $16.17B | $66.28 | +1.4% | +65.4% | Biological products | |
| 57 | CRL Charles River Laboratories | $16.16B | $338.54 | −5.8% | +88.0% | Commercial physical and biological research | |
| 58 | HALO Halozyme Therapeutics Inc | $14.76B | $130.03 | +1.2% | +98.8% | Biological products | |
| 59 | NBIX Neurocrine Biosciences Inc | $14.73B | $145.53 | −0.3% | −1.3% | Biological products | |
| 60 | SOLV Solventum Corp. | $14.43B | $84.75 | +4.2% | +22.8% | Surgical and medical instruments and apparatus | |
| 61 | JAZZ Jazz Pharmaceuticals PLC | $13.16B | $205.06 | −0.8% | +48.5% | Pharmaceutical preparations | |
| 62 | PEN Penumbra Inc | $12.55B | $318.31 | −1.8% | +35.2% | Surgical and medical instruments and apparatus | |
| 63 | BAX Baxter International Inc | $12.53B | $24.22 | +5.3% | +31.4% | Surgical and medical instruments and apparatus | |
| 64 | EHC Encompass Health Corp | $12.04B | $122.09 | +0.5% | −2.6% | Hospitals | |
| 65 | BTSG BrightSpring Health Services, Inc. | $11.83B | $59.46 | +1.9% | +74.9% | Home health care services | |
| 66 | RGEN Repligen Corporation | $11.81B | $184.69 | +5.1% | +21.9% | Biological products | |
| 67 | DVA DaVita HealthCare Partners Inc | $11.68B | $185.74 | −0.9% | +56.1% | Misc health and allied services | |
| 68 | COO The Cooper Companies, Inc | $11.66B | $61.30 | +2.9% | −12.3% | Ophthalmic goods | |
| 69 | TECH Bio-Techne Corp | $11.41B | $72.67 | +0.0% | +16.9% | Biological products | |
| 70 | ELAN Elanco Animal Health | $11.32B | $22.65 | +0.0% | +2.4% | Pharmaceutical preparations | |
| 71 | AVTR Avantor Inc | $11.31B | $16.69 | −2.6% | +10.7% | Laboratory analytical instruments | |
| 72 | ALGN Align Technology Inc | $10.95B | $154.13 | +2.8% | +11.8% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 73 | GMED Globus Medical | $10.91B | $81.26 | +0.4% | +29.5% | Surgical and medical instruments and apparatus | |
| 74 | BMRN Biomarin Pharmaceutical Inc | $10.84B | $56.00 | +1.2% | +4.7% | Pharmaceutical preparations | |
| 75 | ENSG The Ensign Group Inc | $10.74B | $184.11 | +8.6% | −0.7% | Skilled nursing care facilities | |
| 76 | GKOS Glaukos Corp | $10.74B | $181.43 | +0.1% | +133.2% | Surgical and medical instruments and apparatus | |
| 77 | PODD Insulet Corporation | $10.65B | $153.61 | +2.6% | −50.9% | Surgical and medical instruments and apparatus | |
| 78 | UHS Universal Health Services Inc | $10.65B | $180.65 | +2.6% | −16.4% | General medical and surgical hospitals | |
| 79 | MOH Molina Healthcare Inc | $10.34B | $198.10 | −0.7% | +21.7% | Hospital and medical service plans | |
| 80 | BIO Bio-Rad Laboratories Inc | $10.30B | $385.12 | +1.1% | +16.6% | Laboratory analytical instruments | |
| 81 | HSIC Henry Schein Inc | $9.65B | $86.62 | +2.0% | +37.1% | Medical, dental and hospital equipment and supplies | |
| 82 | KRYS Krystal Biotech Inc | $9.52B | $321.42 | +0.3% | +69.5% | Biological products | |
| 83 | BRKR Bruker Corporation | $9.41B | $62.00 | +2.1% | +60.8% | Laboratory analytical instruments | |
| 84 | CORT Corcept Therapeutics Incorporated | $9.33B | $86.28 | −1.5% | +20.6% | Pharmaceutical preparations | |
| 85 | PTGX Protagonist Therapeutics Inc | $9.20B | $142.14 | +0.7% | +81.0% | Pharmaceutical preparations | |
| 86 | TGTX TG Therapeutics Inc | $8.79B | $57.40 | +1.7% | +66.1% | Pharmaceutical preparations | |
| 87 | CYTK Cytokinetics Inc | $8.52B | $61.28 | −0.4% | −1.1% | Pharmaceutical preparations | |
| 88 | ARWR Arrowhead Pharmaceuticals Inc | $8.50B | $60.21 | +2.0% | +52.2% | Pharmaceutical preparations | |
| 89 | ALKS Alkermes Plc | $7.59B | $45.25 | +2.1% | +46.0% | Pharmaceutical preparations | |
| 90 | CHE Chemed Corp | $6.94B | $533.36 | +4.8% | +22.2% | Home health care services | |
| 91 | HIMS Hims Hers Health Inc | $6.84B | $29.32 | +5.0% | −37.8% | Offices and clinics of doctors of medicine | |
| 92 | MSA MSA Safety | $6.83B | $177.16 | −1.1% | +10.2% | Orthopedic, prosthetic and surgical appliances and supplies | |
| 93 | AMRX Amneal Pharmaceuticals, Inc. | $6.75B | $21.14 | −1.4% | +105.4% | Pharmaceutical preparations | |
| 94 | LNTH Lantheus Holdings Inc | $6.53B | $100.10 | −0.1% | +74.6% | In vitro and in vivo diagnostic substances | |
| 95 | LGND Ligand Pharmaceuticals Incorporated | $6.38B | $318.78 | +2.3% | +68.8% | Pharmaceutical preparations | |
| 96 | TFX Teleflex Incorporated | $5.89B | $138.98 | −0.0% | +7.6% | Surgical and medical instruments and apparatus | |
| 97 | RDNT RadNet Inc | $5.79B | $73.54 | +0.0% | −7.0% | Medical laboratories | |
| 98 | MMSI Merit Medical Systems Inc | $5.52B | $92.21 | −1.4% | +11.4% | Surgical and medical instruments and apparatus | |
| 99 | HAE Haemonetics Corporation | $5.38B | $118.32 | −1.4% | +134.9% | Surgical and medical instruments and apparatus | |
| 100 | SHC Sotera Health Co | $5.32B | $18.65 | +0.9% | +12.6% | Misc health and allied services |
The top 100 of 159. The rest of the table needs JavaScript.
‡ Price data for this company stops earlier than the rest; its market value and returns are as of its last price.
Other sectors
A good company is only part of a plan
ReadyAimRetire shows whether your savings, Social Security and spending add up, year by year, before you rely on any single holding.
Questions investors ask
What is the largest health care company in the US?
Eli Lilly (LLY), worth $1.33T on Oct 28, 2026, followed by Johnson & Johnson ($651.32B) and AbbVie ($510.41B).
How are companies placed in sectors?
By each company’s SEC industry code, mapped onto the sectors investors use today. The codes are decades old, so a few companies, such as Alphabet, Meta, Visa and Mastercard, are placed by hand.
How this ranking is built
- Which companies: the 1514 companies with stock pages: the largest US-listed companies by market value that file annual reports (10-Ks) with the SEC. Foreign companies that file 20-F or 40-F reports instead aren’t covered yet, so ranks are among these companies, not every US-listed stock.
- Sectors: from each company’s SEC industry code, mapped onto the sectors investors use today; a few companies, such as Alphabet, Meta, Visa and Mastercard, are placed by hand. “Industry” is the SEC’s own description.
- Market value: the latest close times the shares outstanding on the cover of the latest 10-K or 10-Q. For a company with several share classes, every class is counted; for depositary shares, the shares each one represents.
- Prices and returns: daily closing prices through Oct 28, 2026. Returns include dividends, reinvested. Financial figures come from each company’s latest 10-K, so fiscal years end on different dates.
- Updates: the rankings are recomputed from the stock pages’ own figures whenever those change, so the two always agree.
For education only, not a recommendation to buy or sell any stock. Past results do not predict future results.